Bárbara Angulo
23 works · 979 citations · h-index 15
Top works
- Molecular Context of theEGFRMutations: Evidence for the Activation of mTOR/S6K Signaling
- A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS Mutations
- A gene-alteration profile of human lung cancer cell lines
- A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry
- Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells
- The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung
- Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer
- Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method
- Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for Vemurafenib
- Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study
- Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab
- Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer
- The ALK translocation in advanced non‐small‐cell lung carcinomas: preapproval testing experience at a single cancer centre
- A new generation of companion diagnostics: cobasBRAF, KRASandEGFRmutation detection tests
- Aligning digital CD8+ scoring and targeted next‐generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early‐stage squamous cell lung carcinoma
- P1.02-043 Multiplexed FISH (ALK/ROS1, RET, NTRK1) in Lung Adenocarcinomas: Novel Dual ALK/ROS1 Probe and Automated Scanning System
- Detection of actionable oncogene drivers alterations in HER2-amplified gastric cancer by next generation sequencing.
- PI3K upregulation as a negative predictive factor of survival in HER2 amplified gastric cancer treated with Trastuzumab.
- Real-World Evaluation of Next-Generation Sequencing in Lung Cancer: Associations Between Histological Subtypes and Genomic Alterations
- Organization and results of the EGFR mutation Spanish quality control program